Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Equity Ratio (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Equity Ratio data on record, last reported at 0.5 in Q4 2025.

  • For Q4 2025, Equity Ratio fell 5.07% year-over-year to 0.5; the TTM value through Dec 2025 reached 0.5, down 5.07%, while the annual FY2025 figure was 0.5, 5.07% down from the prior year.
  • Equity Ratio reached 0.5 in Q4 2025 per ORGO's latest filing, roughly flat from 0.5 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.62 in Q3 2024 and bottomed at 0.48 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.55, with a median of 0.56 recorded in 2022.
  • Peak YoY movement for Equity Ratio: surged 234.05% in 2021, then fell 19.82% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.54 in 2021, then rose by 8.59% to 0.59 in 2022, then rose by 2.46% to 0.61 in 2023, then decreased by 12.83% to 0.53 in 2024, then decreased by 5.07% to 0.5 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.5 in Q4 2025, 0.5 in Q3 2025, and 0.51 in Q2 2025.